Quantcast

Latest Prostate cancer Stories

2014-06-06 12:24:27

SANTA MONICA, Calif., June 6, 2014 /PRNewswire/ -- Kite Pharma, Inc., a clinical-stage biotechnology company focused on developing engineered autologous T cell therapy (eACT(TM)) products for cancer, today announced that it has entered into an exclusive, worldwide license with the National Institutes of Health (NIH) to certain intellectual property related to T Cell Receptor (TCR)-based product candidates that target the NY-ESO-1 antigen for the treatment of cancers expressing...

2014-06-06 08:24:52

Initial clinical experience with 89Zr-labeled anti-PSMA minibody presented LOS ANGELES, June 6, 2014 /PRNewswire/ -- ImaginAb, Inc., in collaboration with Memorial Sloan-Kettering Cancer Center (MKSCC), will be presenting initial clinical data with an anti-PSMA recombinant antibody fragment (a "minibody") derived from the huJ591 monoclonal antibody, in patients with metastatic prostate cancer. The presentation of this initial data coincides with the Company's preparation to expand...

2014-06-04 16:26:11

QUEBEC CITY, June 4, 2014 /PRNewswire/ - DiagnoCure, Inc. (TSX: CUR) (OTCQX: DGCRF) (the "Corporation") today reported financial and operational results for the second quarter 2014 ended April 30, 2014. The Corporation announced a net loss of $536,597 or $0.01 per share for this quarter compared with a loss of $849,344 or $0.02 per share for the same period last year. During the second quarter ended April 30, 2014, total revenues decreased by 21% compared with the same quarter of...

2014-06-04 12:29:56

BETHESDA, Md., June 4, 2014 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for cancer, announced today that Linda F. Powers, CEO, will present at the Jefferies 2014 Global Healthcare Conference, which is being held in New York. http://photos.prnewswire.com/prnvar/20110329/SF73084LOGO NW Bio's presentation will take place on Wednesday, June 4, at 2:00 p.m. EDT in Ballroom 5 at the...

2014-06-04 12:29:19

Skyline Radiation Oncology, first in state to use Clarity, now also offers precise stereotactic radiotherapy for prostate cancer due to increased disease targeting confidence TUSTIN, Calif., June 4, 2014 /PRNewswire/ -- Skyline Radiation Oncology's acquisition of Elekta's Clarity® soft tissue visualization system is enabling physicians to continuously track the motion of the prostate during the delivery of radiation therapy. With continuous intrafractional image guidance, Skyline is...

2014-06-04 12:25:59

CRANFORD and STONE HARBOR, N.J., June 4, 2014 /PRNewswire/ -- It is estimated that 1 man in 6 will be diagnosed with prostate cancer in his lifetime, so why aren't more men talking about it? Patrick Walsh author of Still Smiling A Conversation With A Prostate Cancer Survivor (available on amazon.com) thinks he knows the answer - fear and ignorance. In Still Smiling, Walsh a prostate cancer survivor takes aim at these mindsets by telling the story of his journey through fear and ignorance and...

2014-06-03 23:17:27

DiaperBuys, a national online retailer of incontinence supplies, is celebrating Men’s Health Month throughout the month of June with special savings on products especially designed to help males who suffer from incontinence. Wixom, MI (PRWEB) June 03, 2014 DiaperBuys, a national online retailer of incontinence supplies, is celebrating Men’s Health Month throughout the month of June with special savings on products especially designed to help males who suffer from incontinence. While...

2014-06-03 23:14:11

EnergyFirst ProEnergy is being used in a University of Southern California prostate cancer study to see if EnergyFirst’s whey protein isolate powder can restore muscle mass, build strength and provide immune system support to patients. Manhattan Beach, CA (PRWEB) June 03, 2014 EnergyFirst, a world leader in nutraceuticals and nutrition supplementation, is part of a clinical trial involving the effects of whey protein powder and resistance training on patients that are in the process of...

2014-06-03 15:54:17

Rice University Animal tests show Rice-developed technology effective against aggressive cancer The first preclinical study of a new Rice University-developed anti-cancer technology found that a novel combination of existing clinical treatments can instantaneously detect and kill only cancer cells -- often by blowing them apart -- without harming surrounding normal organs. The research, which is available online this week Nature Medicine, reports that Rice's "quadrapeutics" technology...

2014-06-03 12:39:42

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:The Prostate Cancer Therapeutics Market 2013-2023http://www.reportbuyer.com/pharma_healthcare/treatments/prostate_cancer_therapeutics_market_2013_2023.html Report DetailsProstate cancer therapeutics - assess products, developments, and revenue prospectsHow are the leading segments in the prostate cancer therapeutics market performing? Visiongain's new report shows you their prospects to 2023....


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.